Osmotherapy for increased intracranial pressure: comparison between mannitol and glycerol
- PMID: 9309287
- DOI: 10.1007/BF01420045
Osmotherapy for increased intracranial pressure: comparison between mannitol and glycerol
Abstract
Osmotic agents are still the most common treatment for controlling intracranial hypertension (ICH). Mannitol, glycerol, sorbitol, and hypertonic serum saline are the agents currently available. This work was designed to compare mannitol and glycerol in a similar population of brain injured patients, randomly divided into two groups of eight. The following mean day parameters were obtained: number of infusions, hydric balance, mean arterial pressure (MAP), and intracranial pressure (ICP). Cerebral perfusion pressure (CPP) was calculated. Brain computed tomographies (CT) were obtained on arrival, at follow-up whenever justified and at discharge. For comparison of both groups a modified therapeutic intensity level (mTIL) was used. Both agents induced a statistically equally effective decrease on ICP and increase on CPP evaluated at one and two hours post infusion but the mean day mTIL showed a statistically significant difference in favour of glycerol. The possible explanations of this difference are discussed. According to our results mannitol would be most indicated as a bolus to control sudden rises in ICP whereas glycerol would be most indicated as a basal treatment.
Similar articles
-
Comparative effects of hypothermia, barbiturate, and osmotherapy for cerebral oxygen metabolism, intracranial pressure, and cerebral perfusion pressure in patients with severe head injury.Acta Neurochir Suppl. 1998;71:22-6. doi: 10.1007/978-3-7091-6475-4_7. Acta Neurochir Suppl. 1998. PMID: 9779133
-
A Comparative Study of Bolus Dose of Hypertonic Saline, Mannitol, and Mannitol Plus Glycerol Combination in Patients with Severe Traumatic Brain Injury.World Neurosurg. 2019 May;125:e221-e228. doi: 10.1016/j.wneu.2019.01.051. Epub 2019 Jan 24. World Neurosurg. 2019. PMID: 30684710 Clinical Trial.
-
Hypertonic saline reduces cumulative and daily intracranial pressure burdens after severe traumatic brain injury.J Neurosurg. 2015 Jan;122(1):202-10. doi: 10.3171/2014.10.JNS132545. J Neurosurg. 2015. PMID: 25380107 Clinical Trial.
-
[Pharmacodynamics and pharmacokinetics of therapeutic osmoregulating agents in increased intracranial pressure].Zentralbl Neurochir. 1997;58(3):127-33. Zentralbl Neurochir. 1997. PMID: 9446463 Review. German. No abstract available.
-
A Comparison of Pharmacologic Therapeutic Agents Used for the Reduction of Intracranial Pressure After Traumatic Brain Injury.World Neurosurg. 2017 Oct;106:509-528. doi: 10.1016/j.wneu.2017.07.009. Epub 2017 Jul 14. World Neurosurg. 2017. PMID: 28712906 Review.
Cited by
-
Validated ¹H and 13C Nuclear Magnetic Resonance Methods for the Quantitative Determination of Glycerol in Drug Injections.Molecules. 2018 May 15;23(5):1177. doi: 10.3390/molecules23051177. Molecules. 2018. PMID: 29762466 Free PMC article.
-
Glycerol adjuvant therapy in adults with bacterial meningitis in a high HIV seroprevalence setting in Malawi: a double-blind, randomised controlled trial.Lancet Infect Dis. 2011 Apr;11(4):293-300. doi: 10.1016/S1473-3099(10)70317-0. Epub 2011 Feb 18. Lancet Infect Dis. 2011. PMID: 21334262 Free PMC article. Clinical Trial.
-
Multimodality monitoring consensus statement: monitoring in emerging economies.Neurocrit Care. 2014 Dec;21 Suppl 2:S239-69. doi: 10.1007/s12028-014-0019-3. Neurocrit Care. 2014. PMID: 25208665 Review.
-
Guidelines for the Acute Treatment of Cerebral Edema in Neurocritical Care Patients.Neurocrit Care. 2020 Jun;32(3):647-666. doi: 10.1007/s12028-020-00959-7. Neurocrit Care. 2020. PMID: 32227294 Free PMC article.
-
A 28-days sub-acute toxicity study in swiss albino mice to evaluate toxicity profile of neurotol plus (mannitol and glycerol combination).Int J Biomed Sci. 2009 Dec;5(4):428-33. Int J Biomed Sci. 2009. PMID: 23675168 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical